Publications by authors named "B M Reuter"

Purpose: Different techniques of slope-decreasing anterior closed-wedge proximal tibial osteotomy (ACW-PTO) have been described. To determine the peri- and post-operative complication rate and obtain data on bone healing in ACW-PTO with an infratuberositary approach.

Methods: A total of 170 consecutive ACW-PTO of two sports-orthopaedic centres were retrospectively evaluated (97 and 73, respectively).

View Article and Find Full Text PDF

We present the case of a preventive tibial plateau flexion osteotomy in an adolescent patient who had a reduced posterior slope of the tibial plateau. The patient was asymptomatic and without instability at the time. However, magnetic resonance imaging (MRI) showed a dysmorphic posterior cruciate ligament, which was interpreted as an indication for osteotomy.

View Article and Find Full Text PDF

Immunization through repeated direct venous inoculation of Plasmodium falciparum (Pf) sporozoites (PfSPZ) under chloroquine chemoprophylaxis, using the PfSPZ Chemoprophylaxis Vaccine (PfSPZ-CVac), induces high-level protection against controlled human malaria infection (CHMI). Humoral and cellular immunity contribute to vaccine efficacy but only limited information about the implicated Pf-specific antigens is available. Here, we examined Pf-specific antibody profiles, measured by protein arrays representing the full Pf proteome, of 40 placebo- and PfSPZ-immunized malaria-naïve volunteers from an earlier published PfSPZ-CVac dose-escalation trial.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic glucocorticoids, like prednisolone and dexamethasone, are often used to treat idiopathic sudden sensorineural hearing loss (ISSNHL), but it's unclear if higher doses are more effective or riskier than lower doses.
  • In a study with 325 patients, groups were given different regimens: high-dose intravenous prednisolone, high-dose oral dexamethasone, or lower-dose oral prednisolone.
  • Results showed that while there were improvements in hearing, high-dose therapies (HD-Pred and HD-Dex) did not outperform lower-dose treatment (Pred-Control) and were associated with more adverse side effects.
View Article and Find Full Text PDF